5-HT1A RECEPTORS IN THE MEDIAN RAPHE NUCLEUS AND DORSAL HIPPOCAMPUS MAY MEDIATE ANXIOLYTIC AND ANXIOGENIC BEHAVIORS RESPECTIVELY

被引:131
|
作者
ANDREWS, N [1 ]
HOGG, S [1 ]
GONZALEZ, LE [1 ]
FILE, SE [1 ]
机构
[1] UNITED MED & DENT SCH,GUYS HOSP,DIV PHARMACOL,PSYCHOPHARMACOL RES UNIT,LONDON SE1 9RT,ENGLAND
关键词
MEDIAN RAPHE NUCLEUS; DORSAL HIPPOCAMPUS; 5-HT1A RECEPTOR; SOCIAL INTERACTION; GROOMING; (RAT);
D O I
10.1016/0014-2999(94)00473-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The behavioural response of rats in the high light unfamiliar condition of the social interaction test of anxiety was observed following direct administration of the 5-HT1A receptor agonist, (i)-8-hydroxy-dipropylaminotetralin (8-OH-DPAT, 50, 100 or 200 ng) or antagonist tertatolol (3 mu g) into the median raphe nucleus or dorsal hippocampus. In the median raphe nucleus, 8-OH-DPAT (200 ng) significantly increased social interaction without changing locomotor activity; lower doses were inactive. In the dorsal hippocampus, bilateral injection of 8-OH-DPAT (100 ng) significantly decreased social interaction, without effect on locomotor activity; both 50 and 100 ng significantly changed grooming. Tertatolol had no effect on social interaction following administration to the median raphe nucleus, but significantly increased locomotor activity. Bilateral injection of tertatolol into the dorsal hippocampus decreased social interaction and changed grooming. These effects are similar to those of 8-OH-DPAT suggesting tertatolol may have 5-HT1A receptor agonist properties. In conclusion, the findings of this study demonstrate that 5-HT1A somatodendritic autoreceptors and post-synaptic receptors mediate anxiolytic and anxiogenic effects, respectively, in the social interaction test.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 50 条
  • [1] 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus
    Dos Santos, Lucineia
    de Andrade, Telma G. C. S.
    Junior, Helio Zangrossi
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (04) : 286 - 294
  • [2] Anxiolytic effect of estradiol in the median raphe nucleus mediated by 5-HT1A receptors
    Andrade, TGCS
    Nakamuta, JS
    Avanzi, V
    Graeff, FG
    BEHAVIOURAL BRAIN RESEARCH, 2005, 163 (01) : 18 - 25
  • [3] Modulation of 5-HT1A receptors in the dorsal raphe and dorsal hippocampus by intraventricular galanin
    Razani, H
    Diaz-Cabiale, Z
    Fuxe, K
    Ögren, SO
    NORDIC JOURNAL OF PSYCHIATRY, 2000, 54 (02) : 100 - 101
  • [4] The influence of 5-HT1A receptors in the dorsal raphe nucleus on genioglossus activity
    Zou, Ying
    Wang, Wei
    Jin, Hongyu
    Nie, Xinshi
    Xu, Jiahuan
    Liu, Ying
    Kang, Jian
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2018, 249 : 11 - 15
  • [5] Role of 5-HT1A and 5-HT2 receptors of dorsal and median raphe nucleus in tolerance to morphine analgesia in rats
    Nayebi, ARM
    Charkhpour, M
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 83 (02) : 203 - 207
  • [6] Uncontrollable, But Not Controllable, Stress Desensitizes 5-HT1A Receptors in the Dorsal Raphe Nucleus
    Rozeske, Robert R.
    Evans, Andrew K.
    Frank, Matthew G.
    Watkins, Linda R.
    Lowry, Christopher A.
    Maier, Steven F.
    JOURNAL OF NEUROSCIENCE, 2011, 31 (40): : 14107 - 14115
  • [7] ELECTROPHYSIOLOGICAL EVIDENCE THAT SPIPERONE IS AN ANTAGONIST OF 5-HT1A RECEPTORS IN THE DORSAL RAPHE NUCLEUS
    LUM, JT
    PIERCEY, MF
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 149 (1-2) : 9 - 15
  • [8] 5-HT1A agonist potential of pindolol:: Electrophysiologic studies in the dorsal raphe nucleus and hippocampus
    Sprouse, J
    Braselton, J
    Reynolds, L
    BIOLOGICAL PSYCHIATRY, 2000, 47 (12) : 1050 - 1055
  • [9] Postsynaptic 5-HT1A receptors are involved in dorsal raphe nucleus 5-HT neurones activity
    Martín-Ruiz, R
    Ugedo, L
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 349 - 349
  • [10] Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-HT1A and not by muscarinic M1 receptors
    Kenny, PJ
    Cheeta, S
    File, SE
    NEUROPHARMACOLOGY, 2000, 39 (02) : 300 - 307